Jason M. Foster, MD
Dr. Jason M. Foster is a general surgeon, surgical oncologist, and Professor in the Department of Surgery at the University of Nebraska Medical Center. He specializes in surgery for patients diagnosed with cancers of the gastrointestinal tract, peritoneal-based malignancies, and other cancers.[1]
Education and Career
Dr. Foster earned his undergraduate degree at Bucknell University, where he earned a Bachelor of Science in Chemistry. He then moved on to Temple University School of Medicine, where he earned his medical degree.
He completed his internship and residency in General Surgery at Case Western Reserve University /University Hospital of Cleveland. He completed a Basic Science Research Fellowship at Case Western Reserve, followed by a Surgical Oncology fellowship at Roswell Park Cancer Institute and another fellowship in Gastrointestinal and Mixed Tumor Oncology there.[1]
Following his fellowships, he spent four years as an Assistant Professor of Surgery at Creighton University in Omaha, Nebraska, and then joined the University of Nebraska Medical Center’s Department of Surgical Oncology.
Dr. Foster is currently a professor in the Division of Surgical Oncology. He sees patients at the Fred & Pamela Buffett Cancer Center in Omaha, Nebraska.
Dr. Foster specializes in treating peritoneal malignancies, including peritoneal mesothelioma, GI cancers, SKin cancers, and sarcomas.
Among his many skills is the complex surgical procedure called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC). The procedure begins with removing visible tumors from inside the abdominal cavity, and then bathing the cavity with a heated chemotherapy solution to kill any microscopic cancer cells left behind. This procedure has proven effective in the treatment of peritoneal mesothelioma.
Dr. Foster also has technical expertise in the use of intra-operative ultrasound, open and laparoscopic surgery, diagnostic and therapeutic endoscopy, and minimally invasive resection of tumors.
Dr. Foster limits his practice to oncologic diseases, with the exception of conditions that might arise in patients he is already treating for cancer, or for special requests for complex general surgery conditions of the GI tract.
Research
Dr. Foster is actively engaged in clinical and basic science research for peritoneal surface malignancies and gastrointestinal cancer.
He also investigates the autocrine and paracrine biological effects of TGFβperturbations in colon cancer that facilitate and inhibit tumor progression. He is a frequent presenter at local, national, and international medical meetings.[1]
